Article Details
Retrieved on: 2023-12-14 14:06:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here